Age-related hearing loss (ARHL), one of the four most prevalent chronic conditions in the elderly, is associated with low serum levels of folic acid, according to new research published in the December 2010 issue of Otolaryngology – Head and Neck Surgery…
Original post: Age-Related Hearing Loss And Folate In The Elderly
Surgery to remove tumors under the brain known as acoustic neuromas produces favorable outcomes in the “vast majority” of patients, according to one of the largest studies of its kind. Loyola University Hospital surgeons Dr. Douglas Anderson and Dr. John Leonetti followed 730 patients whom they had jointly operated on during a 21-year period…
Original post: Surgery Benefits The ‘Vast Majority’ Of Acoustic Tumor Patients
Tinnitus what many think of as “ringing in the ears” is the perception of sound without any real acoustic stimulation. Sound masking therapy, a common component of tinnitus treatment, is of uncertain benefit when used on its own, a new evidence review finds. Tinnitus sufferers might hear one sound or multiple ones; they can hear them continuously or intermittently…
Original post: “White-Noise” Therapy Alone Not Enough To Curb Tinnitus
Like the mute button on the TV remote control, our brains filter out unwanted noise so we can focus on what we’re listening to. But when it comes to following our own speech, a new brain study from the University of California, Berkeley, shows that instead of one homogenous mute button, we have a network of volume settings that can selectively silence and amplify the sounds we make and hear…
Original post: Our Brains Are Wired So We Can Better Hear Ourselves Speak, New Study Shows
If you know what this is and where it’s located, you could win a prize in the CNET Road Trip Picture of the Week challenge.
Original post: Road Trip Pic of the Week, 1/13: What is this?
Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of and accepted for review the March 15, 2010 resubmission of the Biologics License Application (BLA) for KRYSTEXXAâ„ (pegloticase), a treatment for chronic gout in patients refractory to conventional therapy…
Original post: Savient Announces KRYSTEXXA(TM) Resubmitted BLA Accepted For Review By The FDA
The massively popular, user-created encyclopedia hits a decade tomorrow, having thrived despite a series of controversies. Now, with data suggesting its growth has plateaued, how will the project evolve over the next 10 years?
Original post: At 10, highlighting Wikipedia’s past and future
